CLINICAL TRIALS PROFILE FOR CLONIDINE
✉ Email this page to a colleague
All Clinical Trials for CLONIDINE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00000279 ↗ | Novel Medications for Opiate Detoxification - 4 | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | 1994-09-01 | The purpose of this study is to evaluate novel medications for opiate detoxification. |
NCT00000279 ↗ | Novel Medications for Opiate Detoxification - 4 | Completed | VA Connecticut Healthcare System | Phase 2 | 1994-09-01 | The purpose of this study is to evaluate novel medications for opiate detoxification. |
NCT00000279 ↗ | Novel Medications for Opiate Detoxification - 4 | Completed | Yale University | Phase 2 | 1994-09-01 | The purpose of this study is to evaluate novel medications for opiate detoxification. |
NCT00000800 ↗ | Methadone Effects on Zidovudine (ZDV, AZT) Disposition | Completed | Glaxo Wellcome | Phase 1 | 1969-12-31 | To determine whether methadone maintenance alters the pharmacokinetics of zidovudine (AZT). To determine whether any such effect of methadone on disposition of AZT is time dependent and whether a metabolic interaction between AZT and methadone exists. Injection drug users represent an increasing proportion of HIV-infected persons. Since daily methadone maintenance is the major chemical treatment for injection drug abuse, it is important to determine the impact of methadone on AZT absorption, distribution, and elimination. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CLONIDINE
Condition Name
Clinical Trial Locations for CLONIDINE
Trials by Country
Clinical Trial Progress for CLONIDINE
Clinical Trial Phase
Clinical Trial Sponsors for CLONIDINE
Sponsor Name